Roche Holding AG (TSX:ROG)

Market Cap	410.15B
Revenue (ttm)	108.88B
Net Income (ttm)	16.17B
Shares Out	n/a
EPS (ttm)	20.14
PE Ratio	25.36
Forward PE	14.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	936
Average Volume	27,392
Open	21.40
Previous Close	21.33
Day's Range	21.40 - 21.46
52-Week Range	18.42 - 24.40
Beta	n/a
RSI	47.13
Earnings Date	Oct 27, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Other
• Founded: 1896
• Employees: 103,249
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ROG

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF